Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation - podcast cover

Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation

David Brühlmann - CMC Development Leader, Biotech C-level Advisor, Business Strategistsmartbiotechscientist.com

The Go-to Podcast for Biotech Scientists Who Want to Master Biopharma CMC Development and Biomanufacturing.

**TOP 10 LIFE SCIENCES PODCAST**

Are you ready to simplify bioprocess development and scale with confidence to reduce time to market?

Are you feeling overwhelmed by the complexity and guesswork of biologics development and biomanufacturing?

Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercialization?

There's a way to simplify and streamline so you can remove complexity, skip trials and errors, deliver your groundbreaking therapy to clinics and market without delay, and still enjoy every single step.

I'm David Brühlmann, a biotech entrepreneur and strategic advisor who partners with C-level biopharma leaders to tackle one of our industry's biggest challenges: reducing manufacturing costs to make lifesaving therapies accessible to more patients worldwide.

Through engaging conversations with industry pioneers and practical insights from the trenches, this podcast tackles the critical challenges in bioprocess CMC development and manufacturing of recombinant proteins and cell and gene therapy products. We cut through the complexity so you can:

  • Master bioprocess development with confidence and clarity


  • Excel at scale-up and manufacturing of biologics


  • Transform your innovative therapy and manufacturing technology into market-ready solutions faster


  • Optimize manufacturing costs without compromising quality


  • Make data-driven decisions that reduce the risk of failure


I can’t wait to help you do biotech the smart way.

Grab a cup of coffee and your favorite notebook and pen. Now is the time to take your bioprocessing game to the next level.

Ready to transform your biomanufacturing journey? Let's dive in!

Next Steps:

Book a free assessment to reduce biomanufacturing costs and make lifesaving therapies more accessible: https://bruehlmann-consulting.com/assessment

Fast-track bioprocess development with expert guidance: https://bruehlmann-consulting.com

Visit the Website: https://smartbiotechscientist.com

Email us: [email protected]

Episodes

75: Transforming Single-Cell Analysis With Impedance Flow Cytometry w/ Furkan Gökçe - Part 1

Send us a text Ever wondered how single-cell analysis could revolutionize bioprocessing? Join us in this episode as we delve into the cutting-edge world of impedance flow cytometry. Furkan Gökçe, New Business Development Manager at Amphasys, shares his insights on the transformative power of this technology in the biotech industry. With a background in engineering and physics, Furkan provides a unique perspective on tackling the complexities of biological systems. Key Takeaways: Enhanced Process...

Jul 30, 202417 minEp. 75

74: Bead-Based Assays: The Power of High-Throughput Screening w/ Sebastian Giehring - Part 2

Send us a text Dive into the transformative world of bead-based assays with Sebastian Giehring, CEO and founder of PAIA Biotech, where high-throughput screening meets cutting-edge biotechnological advancements. Join us as we chat with Sebastian, a seasoned scientist and entrepreneur who has revolutionized the workflow of high-throughput screening of titer, glycosylation, and aggregation with innovative bead-based assays. Key Takeaways: Streamlined Workflow: Learn how a simplified sample prep can...

Jul 25, 202417 minEp. 74

73: Bead-Based Assays: The Power of High-Throughput Screening w/ Sebastian Giehring - Part 1

Send us a text Ready to revolutionize your lab work? Join us as we dive deep into bead-based assays with Sebastian Giehring, CEO and founder of PAIA Biotech. Discover how these tiny beads are making a massive impact on biotech research and development — for titer, glycan, and aggreation screening — and how this developability screening platform can enhance your antibody discovery, antibody engineering and lead optimization. In this episode, you’ll learn: Speed and Simplicity: How bead-based assa...

Jul 23, 202419 minEp. 73

72: Effective Outsourcing: How Small Biotech Companies Can Thrive w/ Mark Melville - Part 2

Send us a text How do small biotech companies make strategic decisions with limited resources? This episode dives deep into the art of prioritization and outsourcing to achieve success. Join us as we speak with Mark Melville, Vice President of CMC, Biologics at Cullinan Therapeutics, a seasoned biotech scientist with years of experience in both large and small biotech companies. Mark shares his invaluable insights on navigating the complexities of bioprocess development and outsourcing. In this ...

Jul 18, 202422 minEp. 72

71: Effective Outsourcing: How Small Biotech Companies Can Thrive w/ Mark Melville - Part 1

Send us a text Are you navigating the complex world of bioprocess CMC development and manufacturing in a small biotech company? Our latest episode is a must-listen! Join us as we sit down with Mark Melville, Vice President of CMC, Biologics at Cullinan Therapeutics, who shares invaluable insights on overcoming the unique challenges faced by small biotech firms. In this episode, we explore: The critical communication strategies needed for successful outsourcing to CDMOs. How small biotechs can le...

Jul 16, 202419 minEp. 71

70: Glycoanalytics Explained: Analysing and Designing Better Biopharmaceutical Drugs w/ Róisín O’Flaherty - Part 2

Send us a text In this insightful episode, we explore the cutting-edge field of glycoengineering and its transformative impact on biopharmaceutical drug design. Join us as we chat with Róisín O’Flaherty, Assistant Professor in the Department of Chemistry at Maynooth University, to uncover the nuances of chemoenzymatic glycogen engineering and its potential to revolutionize therapeutics. Key Takeaways: Understanding Glycoengineering: Discover the three main approaches—genetic, metabolomic, and ch...

Jul 11, 202416 minEp. 70

69: Glycoanalytics Explained: Analysing and Designing Better Biopharmaceutical Drugs w/ Róisín O’Flaherty - Part 1

Send us a text Uncover the hidden science behind creating safer, more effective biological drugs! Dive into glycoanalytics and glycoengineering, the secret weapons revolutionizing biopharma. Join us as we talk with Róisín O’Flaherty, Assistant Professor in the Department of Chemistry at Maynooth University, who breaks down the complexities of glycosylation and its pivotal role in drug development. Key Takeaways: Critical Quality Attributes: Understand how glycans influence the function and struc...

Jul 09, 202418 minEp. 69

68: How Process Mapping Transforms Knowledge Management in Biotech w/ Irwin Hirsh - Part 2

Send us a text Join us as we explore the pivotal role of process mapping in biotech knowledge management. Our guest, Irwin Hirsh, a seasoned biotech consultant concentrating on enhancing business efficiency and effectiveness, shares invaluable insights into leveraging technology to streamline operations. Key Insights: Identifying Critical Process Knowledge: Learn strategies to identify and manage vital process knowledge essential for optimal performance. Transitioning from Implicit to Explicit K...

Jul 04, 202429 minEp. 68

67: How Process Mapping Transforms Knowledge Management in Biotech w/ Irwin Hirsh - Part 1

Send us a text Want to turn your biotech chaos into streamlined success? Learn from expert Irwin Hirsh, a seasoned biotech consultant concentrating on enhancing business efficiency and effectiveness, on how process mapping can transform your knowledge management and elevate your business performance. Key Takeaways: Eliminate Scope Creep: Learn how to maintain focus in projects despite shifts and changes, improving productivity and reducing frustration. Bridge Experience Gaps: Understand how proc...

Jul 02, 202414 minEp. 67

66: Freezing and Thawing Cells: the Science Behind Cryopreservation w/ Mark Davison - Part 2

Send us a text Get ready to dive into the fascinating world of cryopreservation! In this episode, we welcome Mark Davison, an experienced entrepreneur and CEO of Grant Instruments, leaders in laboratory equipment, to explore the intricate science of freezing and thawing cells. Mark brings his wealth of experience to demystify this crucial process, revealing how cutting-edge technology ensures precision and reliability in preserving biological samples. Key Takeaways: Mastering Precision: Learn ho...

Jun 27, 202416 minEp. 66

65: Freezing and Thawing Cells: the Science Behind Cryopreservation w/ Mark Davison - Part 1

Send us a text Picture a world where we can freeze cells and bring them back to life perfectly intact. In this episode, we're joined by Mark Davison, a leading expert in cryopreservation and CEO of Grant Instruments to uncover the intricate science of freezing and thawing cells. From basic principles to advanced techniques, we delve into how cryopreservation is revolutionizing biotechnology and cell therapies. Key Takeaways: Cell Survival Secrets: Discover why water is both a friend and foe...

Jun 25, 202424 minEp. 65

64: Why Sound Waves Are the Future of Gene Therapy Bioreactors w/ Gabriel Dumy - Part 2

Send us a text Could sound waves be the revolutionary key to gene therapy manufacturing? In this episode, Gabriel Dumy, CTO and Co-founder at Kolibri, reveals how acoustic waves are set to transform cell harvesting and gene transfection processes, making biomanufacturing more efficient and less damaging to cells. Kolibri is a company revolutionizing the way we grow and engineer cells at scale using acoustic waves. Key Takeaways: Real-Time Cell Harvesting: Discover how reconfigurable acoustic wav...

Jun 20, 202422 minEp. 64

63: Why Sound Waves Are the Future of Gene Therapy Bioreactors w/ Gabriel Dumy - Part 1

Send us a text Are sound waves the key to revolutionizing gene therapy? In this groundbreaking episode, we sit down with Gabriel Dumy, CTO and Co-founder at Kolibri, a company revolutionizing the way we grow and engineer cells at scale using acoustic waves. Gabriel shares the challenges facing modern bioproduction and unveils an exciting solution that's setting the stage for the future of gene therapy. Key Takeaways: Enhanced Cell Productivity: Discover how acoustic waves minimize shear str...

Jun 18, 202425 minEp. 63

62: Magnetic Bead Technology: The New Era in Downstream Processing w/ Nils Brechmann - Part 2

Send us a text Dive into the future of bioprocessing with Nils Brechmann, Marketing Manager at MAGic BioProcessing and co-inventor of the process applications, as we explore how magnetic bead technology is transforming downstream processing. MAGic BioProcessing is a biotech company from Uppsala, Sweden, that develops magnetic-based recovery of biologicals. Key Takeaways: Streamlined Purification: Discover how magnetic beads enable simultaneous clarification and capture, boosting efficiency. Cost...

Jun 13, 202415 minEp. 62

61: Magnetic Bead Technology: The New Era in Downstream Processing w/ Nils Brechmann - Part 1

Send us a text Dive into the latest episode as we explore how magnetic bead technology is revolutionizing downstream processing, promising higher yields and greater purity. Our guest, Nils Brechmann, Marketing Manager at MAGic BioProcessing and co-inventor of the process applications, shares his insights on overcoming industry challenges and the future of purification. MAGic BioProcessing is a biotech company from Uppsala, Sweden, that develops magnetic-based recovery of biologicals. Key Takeawa...

Jun 11, 202419 minEp. 61

60: Next-Generation Sequencing: Transforming Science and Medicine w/ Jonathon Hill - Part 2

Send us a text Unlock the future of epigenetics and join us for an insightful conversation with Jonathon Hill as he delves into the groundbreaking world of next-generation sequencing (NGS) and its transformative impact on science and medicine. Jonathon Hill is the VP of Science and Technology and a co-founder of Wasatch BioLabs and Associate Professor of Cell Biology and Physiology at Brigham Young University. Discover how cutting-edge nanopore technology is overcoming the limitations of traditi...

Jun 06, 202421 minEp. 60

59: Next-Generation Sequencing: Transforming Science and Medicine w/ Jonathon Hill - Part 1

Send us a text Curious about the latest advancements in next-generation sequencing (NGS) and how they are revolutionizing science and medicine? In this episode, we delve into the cutting-edge developments of NGS with our expert guest, Jonathon Hill, VP of Science and Technology and a co-founder of Wasatch BioLabs and Associate Professor of Cell Biology and Physiology at Brigham Young University, who has been at the forefront of this transformative field. Key Takeaways: Discover how NGS is empowe...

Jun 04, 202417 minEp. 59

58: Crafting a Solid CMC Strategy: Key Factors and Common Pitfalls w/ Matthias Müllner - Part 2

Send us a text Dive into the realm of biotech with our latest episode as we unravel the enigma of Quality by Design (QbD) with Matthias Müllner, CEO of & Co-Founder bespark*bio, a company empowering viral vector-based medicines. Discover how integrating QbD principles early in your development cycle can revolutionize your approach to producing safe, high-quality products consistently. From understanding critical quality attributes to designing robust manufacturing processes, we illuminate th...

May 30, 202419 minEp. 58

57: Crafting a Solid CMC Strategy: Key Factors and Common Pitfalls w/ Matthias Müllner - Part 1

Send us a text Join us for an insightful episode as we dive into the world of bioprocess CMC development strategies with Matthias Müllner, CEO of & Co-Founder bespark*bio, a company empowering viral vector-based medicines. Matthias shares his wealth of knowledge on avoiding common pitfalls in developing robust Chemistry, Manufacturing, and Controls (CMC) strategies. He also emphasizes the critical elements that ensure your biotech product's success. Key Takeaways: Start Strong: Establis...

May 28, 202417 minEp. 57

56: Cultivated Meat: A Promising Future or an Inevitable Bubble? w/ Steven Lang - Part 2

Send us a text Is cultivated meat the food of tomorrow or just a passing trend? In this episode, we dive deep with Steven Lang, an expert in the field of cultivated meat. Steven sheds light on the intricate process of creating meat in the lab, the challenges faced, and the potential future of this innovative industry. Key Takeaways: Precision in Analytics: Discover how cutting-edge sensory analytics are crucial for developing cultivated meat that mimics traditional meat's texture and taste....

May 23, 202415 minEp. 56

55: Cultivated Meat: A Promising Future or an Inevitable Bubble? /w Steven Lang - Part 1

Send us a text How can you create an environment suitable for shear-stress-sensitive cells that results in higher cell concentrations and superior quality? Essentially, bionic bioreactors revolutionize this process, changing the game rules with their ability to facilitate bubble-free gas exchange. Join us in this episode as we unravel the groundbreaking innovations in bioreactor technology with our guest, Patrick Bongartz, CEO of BioThrust and the visionary mind behind stress-free cell cultivati...

May 21, 202423 minEp. 55

54: Bionic Bioreactors: The Key to Stress-Free Cell Cultivation w/ Patrick Bongartz - Part 2

Send us a text How can you create an environment suitable for shear-stress-sensitive cells that results in higher cell concentrations and superior quality? Essentially, bionic bioreactors revolutionize this process, changing the game rules with their ability to facilitate bubble-free gas exchange. Join us in this episode as we unravel the groundbreaking innovations in bioreactor technology with our guest, Patrick Bongartz, CEO of BioThrust and the visionary mind behind stress-free cell cultivati...

May 16, 202419 minEp. 54

53: Bionic Bioreactors: The Key to Stress-Free Cell Cultivation w/ Patrick Bongartz - Part 1

Send us a text How can you provide stress-free cultivation conditions to achieve higher cell concentrations and quality? In a nutshell, bionic bioreactors and thus change bubble-free gas exchange change the game. Join us as we delve into the future of biotech with our guest, Patrick Bongartz, CEO of BioThrust and an expert in innovative bioreactor design. Key Highlights: Unveil the groundbreaking "artificial lung," a marvel of engineering that decouples mixing and gas transfer, enablin...

May 14, 202418 minEp. 53

52: Unraveling the Complexity of Commercializing Cell and Gene Therapies w/ Wajiha Ali - Part 2

Send us a text Does the process of commercializing cell and gene therapies seem complex and unclear to you? Dive deep into the groundbreaking world of cell and gene therapies with our guest, Wajiha Ali, a strategy expert who believes in bridging the gap between research and commercialization with data, as we unravel the complexities of bringing life-saving therapies to patients. From cutting-edge technologies to innovative collaboration models, we explore the future landscape of these transforma...

May 09, 202426 minEp. 52

51: Unraveling the Complexity of Commercializing Cell and Gene Therapies w/ Wajiha Ali - Part 1

Send us a text Are you finding the path to commercializing cell and gene therapies complex and uncertain? Join us as we explore this intricate landscape with our guest, Wajiha Ali. As a strategy expert who believes in bridging the gap between research and commericalization with data who she will guide us through the challenges, victories, and vital strategies for successfully bringing these cutting-edge therapies to market. Key Highlights: Discover the amplified complexity of cell and gene thera...

May 07, 202419 minEp. 51

50: Decode Bioprocess Success: The Art of Stakeholder Management - Part 2

Send us a text In the second part of "Decode Bioprocess Success: The Art of Stakeholder Management," we delve deeper into the strategies for effective stakeholder management in bioprocess development. Through a step-by-step approach, we explore how to identify, classify, and engage with stakeholders to ensure project success. Key highlights: Learn how to create a stakeholder management plan tailored to the unique needs and interests of each stakeholder group. Discover the power interes...

May 02, 202411 minEp. 50

49: Decode Bioprocess Success: The Art of Stakeholder Management - Part 1

Send us a text In this episode, we embark on a journey to uncover the essential strategies for navigating stakeholder relationships in bioprocess CMC development projects. We delve into the critical role of stakeholders in bioprocess development and how their engagement can determine the success or failure of a project. Drawing from real-life experiences and insights, we explore the importance of understanding stakeholder needs, interests, and power dynamics. Discover why stakeholder management ...

Apr 30, 202417 minEp. 49

48: Mastering Process Economics: Driving Down Costs in Antibody Production w/ Brian Kelley - Part 2

Send us a text Unlock the secrets to cost-efficient antibody therapeutics with Brian Kelley, Senior Vice President of Process Development at VIR Biotechnology. In this illuminating episode, industry expert Brian Kelley shares invaluable insights into driving down manufacturing costs while maintaining quality and accessibility. From optimizing batch sizes to maximizing titers, discover practical strategies to streamline the process economics of antibody development. Key Takeaways: Scale Matters: ...

Apr 25, 202419 minEp. 48

47: Mastering Process Economics: Driving Down Costs in Antibody Production w/ Brian Kelley - Part 1

Send us a text Join us in this enlightening episode as we explore process economics with industry expert Brian Kelley. He is the Senior Vice President of Process Development at VIR Biotechnology. Unraveling the mysteries of cost management in antibody therapeutics, Brian sheds light on the intricate challenges faced by biotech scientists and engineers. Key Highlights: Discover the nuanced interplay between technical and cultural obstacles in process development. Navigate the labyrinth of cost dr...

Apr 23, 202417 minEp. 47

46: From Lab to Table: The Science Behind Cultivated Meat w/ Petra Hanga - Part 2

Send us a text Dive into the future of food with our latest episode, "From Lab to Table: The Science Behind Cultivated Meat." With our guest, Petra Hanga, a Lecturer in Biochemical Engineering at University College London and Chief Scientific Officer of Quest Meat Ltd., we unravel the secrets behind this groundbreaking technology. Key highlights: 1. Discover how stem cells revolutionize the production of cultivated meat, providing a scalable solution for creating muscle, fat, and conne...

Apr 18, 202426 minEp. 46